PHSSR Saudi Arabia 2025

RECOMMENDATION 4E Encourage research and development (R&D) in medicines and health technologies to foster innovation and development to address the evolving healthcare needs of the population. RECOMMENDATION 4F Foster the use of cost-effectiveness analysis in the evaluation of medicines and health technologies to improve resource allocation and ensure value for money. RECOMMENDATION 4G Promote cost-effective use of generic medicines and biosimilars to improve affordability and accessibility, without compromising quality. 57 Sustainability and Resilience in the Saudi Arabian Health System The Partnership for Health System Sustainability and Resilience